Congestive in Biological Technology
Navigation Links
Congestive in Biological Technology
... cardiac toxicity. Myocardial damage may lead to congestive heart failure and may occur as the total ... should be carefully monitored
congestive heart failure or cardiomyopathy may occur after ... events (including myocardial infarction, stroke, congestive heart failure, and hemodialysis vascular access ...
... intended to prevent or reverse the progression of congestive heart failure in patients who have an enlarged ... heart mitral valve which contributed to congestive heart failure. During the surgery to repair the ... of the left ventricle, which is typical in congestive heart failure. As such, this new therapy has the ...
... evaluating ubiquinol's effects on late-stage congestive heart failure showed that the newly available ... "In 25 years of experience in treating congestive heart failure, we have consistently seen the best ... levels in these seven patients with end-stage congestive heart failure was associated with overall ...
... use in treatment of acute systemic hypertension, congestive heart failure and hemorrhagic shock. The ... the next fiscal year for treatment of acute congestive heart failure; -- Advancing new Palatin ... use in treatment of acute systemic hypertension, congestive heart failure and other diseases. Palatin's ...
... development for treatment of acute decompensated congestive heart failure (CHF). The Phase I trial was ... the subcutaneous route of administration. About congestive Heart Failure (CHF) Currently in the U.S., CHF ... over 1,100,000 hospitalizations for CHF in 2004. congestive heart failure has tremendous human and financial ...
... I clinical trial for MyoCell SDF-1 (Stromal Derived Factor - 1) to treat congestive heart failure. The REGEN trial will enroll 15 patients in a multicenter, ... safety and cardiovascular effects of the implantation of MyoCell SDF-1 in congestive heart failure patients post myocardial infarction(s). MyoCell SDF-1 ...
... vs. 4.5%). Events considered cardiac disorders included cardiac arrest, congestive heart failure, myocardial infarction, cyanosis, pericardial effusion, and ... (initial) treatment, they cause cumulative heart damage that may result in congestive heart failure many years later. As a result, there is a lifetime limit of ...
... of doxorubicin, a dose at which 5.6% of patients are expected to develop congestive heart failure (CHF). At cumulative doses of doxorubicin in excess of ... (initial) treatment, they cause cumulative heart damage that may result in congestive heart failure many years later. As a result, there is a lifetime limit of ...
... brain damage and death. In the treatment of hyponatremia associated with congestive heart failure, Vaprisol is indicated only for those patients for whom ... in hospitalized patients. Vaprisol is not indicated for the treatment of congestive heart failure. It should only be used for the treatment of hyponatremia in ...
... been studied in mantle cell lymphoma. Acute development or exacerbation of congestive heart failure, and/or new onset of decreased left ventricular ejection ... to be possibly related to study drug: including reports of cardiac arrest, congestive heart failure, respiratory failure, renal failure, pneumonia and sepsis. ...
... for the development of lymphoma. The potential role of TNF blocker therapy in the development of malignancies is not known. Cases of worsening congestive heart failure (CHF) and new onset CHF have been reported with TNF blockers. CIMZIA has not been formally studied in patients with CHF. Exercise ...
... and Director of Cardiac and Vascular diseases at Regenocyte Therapeutic, a company successfully treating patients with heart disease such as congestive heart failure and lung disease such as pulmonary fibrosis, COPD, and pulmonary hypertension. Adult stem cells have undergone much more research ...
... therapy for patients with a history of malignancy or when considering continuing treatment in patients who develop malignancy. Worsening congestive heart failure (CHF) and new onset CHF have been reported with TNF blockers. Cases of CHF in patients with known cardiovascular risk factors have been ...
... remodeling leading to further tissue damage over time and downstream adverse events including premature death, recurrent myocardial infarction, congestive heart failure, significant arrhythmias and acute coronary syndrome. Amorcyte's therapy aims to limit ventricular remodeling. About ...
... in patients with HER-2 overexpressing breast cancer; the 3 drug combination was well tolerated with no cases of treatment-related symptomatic congestive heart failure. " Phase III Study Design The study is a global, randomized, multicenter pivotal Phase III study in 363 patients who ...
... in patients with HER-2 overexpressing breast cancer. The 3-drug combination was well tolerated. There were no cases of treatment-related symptomatic congestive heart failure. This is noteworthy because cardiotoxicity is a common and therapy-limiting adverse event of the anthracycline class of anti-cancer ...
... observed to have side effects of weight gain and abdominal obesity, which exacerbate the diabetic condition itself, and to cause edema and exacerbate congestive heart failure in certain patients. Individuals vary in their risk and there is no known method for predicting such side effects. FDA-mandated "black ...
... TZD full PPAR agonists Actos(R) (pioglitazone) and Avandia(R) (rosiglitazone), which while efficacious are associated with weight gain, edema, congestive heart failure and bone fracture. Unlike TZDs, INT131 was specifically selected for its ability to separate powerful PPAR anti-diabetic efficacy from ...
... Fatigue Syndrome and fibromyalgia as well as a general malaise of exhaustion," said Teitelbaum. Corvalen(R) is also used by physicians to treat congestive heart failure and to prepare patients for off-pump bypass surgery(1). "Bioenergy D-Ribose(TM) also has sweeping applications for healthy ...
... in patients treated with CIMZIA(R). There is no evidence that CIMZIA(R) therapy has an effect on in vivo coagulation. Cases of worsening congestive heart failure (CHF) and new onset CHF have been reported with TNF blockers. CIMZIA (R) has not been formally studied in patients with CHF. ...
... seven deaths indicated above. - A third patient who was on pegloticase every 4 weeks, following a placebo dose had an SAE relating to congestive heart failure which was resolved after hospitalization. However, as previously reported, this patient died of renal failure after ...
... test (RAT) for influenza and had one or more criteria for hospitalization, namely: age greater than or equal to 60 years, chronic lung disease, congestive heart failure, diabetes mellitus, low oxygen saturation, low blood pressure, or severity of illness requiring supportive care. Of the 137 patients ...
... Gerson Lehrman Group's leading physician consultants along with executives from public and private equity biotechnology companies to discuss: -- congestive Heart Failure -- Cystic Fibrosis -- Epilepsy -- Fibromyalgia -- Lung Cancer -- Neurodegenerative Diseases -- Novel Solid Tumor Targets ...
... intended to prevent or reverse the progression of congestive heart failure in patients who have an enlarged ... heart mitral valve which contributed to congestive heart failure. During the surgery to repair the ... of the left ventricle, which is typical in congestive heart failure. As such, this new therapy has the ...
... evaluating ubiquinol's effects on late-stage congestive heart failure showed that the newly available ... "In 25 years of experience in treating congestive heart failure, we have consistently seen the best ... levels in these seven patients with end-stage congestive heart failure was associated with overall ...
Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients
... this tremendous opportunity to better serve the congestive Heart Failure patient population and their ... available through physician prescription. ABOUT congestive HEART FAILURE congestive heart failure (CHF), or heart failure, is a ...Bioheart, Inc. Announces Financial Results for First Quarter 2008
... cardiac devices who are experiencing congestive heart failure. -- Bioheart initiated its ... expand our clinical body of evidence in treating congestive heart failure patients. This Phase II/III, ... myoblasts to treat patients suffering from congestive heart failure. These myoblasts, adult stem cells ...... use in treatment of acute systemic hypertension, congestive heart failure and hemorrhagic shock. The ... the next fiscal year for treatment of acute congestive heart failure; -- Advancing new Palatin ... use in treatment of acute systemic hypertension, congestive heart failure and other diseases. Palatin's ...
Genomics Likely to Replace Traditional Drug Therapies in Treating CHF
... NEW YORK, April 17 /PRNewswire/ -- The market for congestive heart failure (CHF) drug treatments was estimated ... to a new report by Kalorama Information, congestive Heart Failure: Major World Markets, Volume I: ... adequate answer. Kalorama Information's report congestive Heart Failure: Major World Markets, Volume I: ...... development for treatment of acute decompensated congestive heart failure (CHF). The Phase I trial was ... the subcutaneous route of administration. About congestive Heart Failure (CHF) Currently in the U.S., CHF ... over 1,100,000 hospitalizations for CHF in 2004. congestive heart failure has tremendous human and financial ...
... I clinical trial for MyoCell SDF-1 (Stromal Derived Factor - 1) to treat congestive heart failure. The REGEN trial will enroll 15 patients in a multicenter, ... safety and cardiovascular effects of the implantation of MyoCell SDF-1 in congestive heart failure patients post myocardial infarction(s). MyoCell SDF-1 ...
Symphony Medical Changes Name to CardioPolymers, Inc.
... biocompatible polymer implants to treat cardiac patients - specifically, congestive heart failure patients with an enlarged left ventricle." ... clinical development intended to prevent or reverse the progression of congestive heart failure in patients with dilated cardiomyopathy, a condition in ...... vs. 4.5%). Events considered cardiac disorders included cardiac arrest, congestive heart failure, myocardial infarction, cyanosis, pericardial effusion, and ... (initial) treatment, they cause cumulative heart damage that may result in congestive heart failure many years later. As a result, there is a lifetime limit of ...
... of doxorubicin, a dose at which 5.6% of patients are expected to develop congestive heart failure (CHF). At cumulative doses of doxorubicin in excess of ... (initial) treatment, they cause cumulative heart damage that may result in congestive heart failure many years later. As a result, there is a lifetime limit of ...
... brain damage and death. In the treatment of hyponatremia associated with congestive heart failure, Vaprisol is indicated only for those patients for whom ... in hospitalized patients. Vaprisol is not indicated for the treatment of congestive heart failure. It should only be used for the treatment of hyponatremia in ...
Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
... been studied in mantle cell lymphoma. Acute development or exacerbation of congestive heart failure, and/or new onset of decreased left ventricular ejection ... to be possibly related to study drug: including reports of cardiac arrest, congestive heart failure, respiratory failure, renal failure, pneumonia and sepsis. ...Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results
... been studied in mantle cell lymphoma. Acute development or exacerbation of congestive heart failure, and/or new onset of decreased left ventricular ejection ... to be possibly related to study drug: including reports of cardiac arrest, congestive heart failure, respiratory failure, renal failure, pneumonia and sepsis. ...... been studied in mantle cell lymphoma. Acute development or exacerbation of congestive heart failure, and/or new onset of decreased left ventricular ejection ... to be possibly related to study drug: including reports of cardiac arrest, congestive heart failure, respiratory failure, renal failure, pneumonia and sepsis. ...
FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
... (23%, 0%), superficial edema (17%, 41%), generalized edema (2%, 4%), congestive heart failure/cardiac dysfunction (2%, 0%), pericardial effusion (1%, ... gastrointestinal bleeding (4%), dyspnea (3%), sepsis (1%), diarrhea (2%), congestive heart failure (2%), and pericardial effusion (1%). Grade 3/4 elevations ...Novel gene found for dilated cardiomyopathy
... women and is most common between the ages of 20 and 60 years, although it also occurs in fetuses, newborns and children. About one in three cases of congestive heart failure is due to DCM, which also occurs in children. Dr. Towbin and his colleagues screened 208 patients, mostly children and young adults, ...... for the development of lymphoma. The potential role of TNF blocker therapy in the development of malignancies is not known. Cases of worsening congestive heart failure (CHF) and new onset CHF have been reported with TNF blockers. CIMZIA has not been formally studied in patients with CHF. Exercise ...
... and Director of Cardiac and Vascular diseases at Regenocyte Therapeutic, a company successfully treating patients with heart disease such as congestive heart failure and lung disease such as pulmonary fibrosis, COPD, and pulmonary hypertension. Adult stem cells have undergone much more research ...
... therapy for patients with a history of malignancy or when considering continuing treatment in patients who develop malignancy. Worsening congestive heart failure (CHF) and new onset CHF have been reported with TNF blockers. Cases of CHF in patients with known cardiovascular risk factors have been ...
Repair Stem Cell Institute Warns About Real Cost of Embryonic Stem Cell Research
... now, every week, improving dozens and dozens of lives all over the world. He emphasized that "Patients stricken with disabling diseases such as congestive heart failure, diabetes, multiple sclerosis, spinal cord injuries, cerebral palsy, muscular dystrophy, ataxia, autism, COPD, emphysema, Crohn's, and ...... remodeling leading to further tissue damage over time and downstream adverse events including premature death, recurrent myocardial infarction, congestive heart failure, significant arrhythmias and acute coronary syndrome. Amorcyte's therapy aims to limit ventricular remodeling. About ...
... in patients with HER-2 overexpressing breast cancer; the 3 drug combination was well tolerated with no cases of treatment-related symptomatic congestive heart failure. " Phase III Study Design The study is a global, randomized, multicenter pivotal Phase III study in 363 patients who ...
... in patients with HER-2 overexpressing breast cancer. The 3-drug combination was well tolerated. There were no cases of treatment-related symptomatic congestive heart failure. This is noteworthy because cardiotoxicity is a common and therapy-limiting adverse event of the anthracycline class of anti-cancer ...
... observed to have side effects of weight gain and abdominal obesity, which exacerbate the diabetic condition itself, and to cause edema and exacerbate congestive heart failure in certain patients. Individuals vary in their risk and there is no known method for predicting such side effects. FDA-mandated "black ...
Inverseon's Asthma Therapy Receives Notice of Allowance; Clinical Trial Highlighted in Lancet
... of certain beta blockers for the treatment of asthma," commented Amie E. Franklin, PhD, of Inverseon. "A similar story played out 10 years ago in congestive heart failure where certain beta blocker drugs have become billion dollar products." "The Lancet Comment on Inverseon's human asthma study ...Victhom announces the completion of the second phase of the apnea therapy development
... disorder that happens mostly during sleep. Apnea is a co-morbidity with other physiological issues such as high blood pressure, heart attack, congestive heart failure, cardiac arrhythmia, stroke or depression. The National Sleep Foundation estimates that more than 18 million American adults suffer ...... TZD full PPAR agonists Actos(R) (pioglitazone) and Avandia(R) (rosiglitazone), which while efficacious are associated with weight gain, edema, congestive heart failure and bone fracture. Unlike TZDs, INT131 was specifically selected for its ability to separate powerful PPAR anti-diabetic efficacy from ...
VivoMetrics to Present at the 2009 Biotech Showcase
... using LifeShirt at nearly 300 leading research and academic institutions across a wide range of disease states, including sleep disordered breathing, congestive heart failure, chronic obstructive pulmonary disease and cystic fibrosis. For more information, visit www.lifeshirt.com . Forward-looking ...... Fatigue Syndrome and fibromyalgia as well as a general malaise of exhaustion," said Teitelbaum. Corvalen(R) is also used by physicians to treat congestive heart failure and to prepare patients for off-pump bypass surgery(1). "Bioenergy D-Ribose(TM) also has sweeping applications for healthy ...
... in patients treated with CIMZIA(R). There is no evidence that CIMZIA(R) therapy has an effect on in vivo coagulation. Cases of worsening congestive heart failure (CHF) and new onset CHF have been reported with TNF blockers. CIMZIA (R) has not been formally studied in patients with CHF. ...
Noninvasive Medical Technologies Helps Make Young Tennessee Woman's Wishes Come True
... and communications solutions for military and civilian medical use. Aiming to improve the odds for people medically at risk from dehydration or congestive heart failure, ORNL and NMT were actively engaged in improving and miniaturizing NMT's proprietary, patented ZOE(TM), an FDA-approved noninvasive ...Neurocrine Biosciences Reports Third Quarter 2008 Results
... a Phase I single dose-escalating clinical trial with a third CRF1 compound, 586529, for the treatment of anxiety and depression. Urocortin 2 for congestive Heart Failure (CHF) Continues Preclinical Evaluation Initiation of longer term (up to 72 hours in duration) Phase II clinical trials of urocortin 2 ...Osteoporosis Drugs Increase Risk for Heart Problems
... heart disease or hypertension," said Jennifer Miranda, MD, Jackson Memorial Hospital, Miami, FL. "If left untreated, it can lead to pulmonary edema, congestive heart failure, or the formation of a blood clot that can cause a brain embolism and stroke." In a metaanalysis, Dr. Miranda and colleagues from the ...... seven deaths indicated above. - A third patient who was on pegloticase every 4 weeks, following a placebo dose had an SAE relating to congestive heart failure which was resolved after hospitalization. However, as previously reported, this patient died of renal failure after ...
... test (RAT) for influenza and had one or more criteria for hospitalization, namely: age greater than or equal to 60 years, chronic lung disease, congestive heart failure, diabetes mellitus, low oxygen saturation, low blood pressure, or severity of illness requiring supportive care. Of the 137 patients ...
... Gerson Lehrman Group's leading physician consultants along with executives from public and private equity biotechnology companies to discuss: -- congestive Heart Failure -- Cystic Fibrosis -- Epilepsy -- Fibromyalgia -- Lung Cancer -- Neurodegenerative Diseases -- Novel Solid Tumor Targets ...
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction
... consider the use of ERBITUX in combination with radiation therapy in head and neck cancer patients with a history of coronary artery disease, congestive heart failure or arrhythmias in light of these risks - Closely monitor serum electrolytes including serum magnesium, potassium, and calcium during ...Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
... complications such as pneumonia. In addition, influenza exacerbates the symptoms of chronic health conditions such as diabetes, asthma and congestive heart failure. The most severe disease occurs in infants and young children and adults older than 65 years of age. The CDC reports that 15 to 60 ...Other ContentsmalnutritionmalnutritionmalnutritionmalnutritionmammogramsmammogramsmammographymammographymammographymaniamaniamaniamaniamammogrammammogrammandibledepressivedepressivedepressivedepressiveOther TagsOrthosisStirrupSoleSESSESSESSESSESSESSESTrexTrexTrex
(Date:12/15/2009)... exact an enormous emotional and economic toll on society. ... rip currents each year in U.S. waters and it,s likely ... worldwide. A serious disconnect exists between rip current research ... rip tides and undertows, and more importantly, most people do ... a rip current. , The goal of the Rip Current ...
(Date:12/14/2009)... are part of an international team that has used ... revise the history of North America,s woolly mammoths and ... Earth and Atmospheric Sciences professor Duane Froese and his ... dating of bones and teeth. That analysis concluded that ... America (the ,megafauna,) disappeared about 13,000 years ago. ...
(Date:12/14/2009)... as a clean-burning, renewable fuel that could help wean ... caused by ozone, compared with gasoline, especially in winter, ... , Ozone production from both gasoline and E85, ... percent ethanol, is greater in warm sunny weather than ... because heat and sunlight contribute to ozone formation. But ...
Breaking Biology News(10 mins):Ethanol-powered vehicles generate more ozone than gas-powered ones 2Ethanol-powered vehicles generate more ozone than gas-powered ones 3Hartfords Camp Courant Gets a Brick Up on Summer Thanks to 24100 000 Grant From The LEGO 28R 29 Childrens Fund 51992 1Hartfords Camp Courant Gets a Brick Up on Summer Thanks to 24100 000 Grant From The LEGO 28R 29 Childrens Fund 51992 2Hartfords Camp Courant Gets a Brick Up on Summer Thanks to 24100 000 Grant From The LEGO 28R 29 Childrens Fund 51992 3Rabies 3A How to Protect Yourself and Your Pets 51990 1Rabies 3A How to Protect Yourself and Your Pets 51990 2Sanford Rose Associates Opens Minneapolis Office 13075 1Sanford Rose Associates Opens Minneapolis Office 13075 2(Date:12/15/2009)... 15 The Food and Health Bureau has ... overseas parties in developing private hospitals at four sites ... for submitting EOI is March 31, 2010. ,, ... Health, Dr. York Chow, said the promotion of private ... reform and a major Hong Kong government policy announced ...
(Date:12/15/2009)... coal for lying about taxes in the healthcare bill ... has earned a place under the "Naughty" column on Americans ... after being caught telling a brazen lie on the floor ... bill would not raise taxes. ,, Speaking on the ... " I have also heard it ...
(Date:12/15/2009)... Our Lady of Lourdes Health Care Services ... has agreed to pay the United States $7.95 million ... Justice Department announced today. The two hospitals are Our ... and Lourdes Medical Center of Burlington County (LMC) in ... a suit brought by a whistleblower, Tony Kite, in ...
(Date:12/15/2009)... reproductive age were evaluated, Italian study found , , TUESDAY, ... born with cystic fibrosis decreases when screening for potential ... new study finds. , CF neonatal screening has been ... years. Since the 1990s, the area has seen a ... with CF. , Two different CF carrier detection methods ...
(Date:12/15/2009)... really been in trouble, expert says , , TUESDAY, Dec. ... H1N1 swine flu has revealed serious flaws in the ... new report says. , The report, prepared by the ... Foundation, also finds the dire economy has strained the ... outbreak is the latest in a series of reminders ...
Breaking Medicine News(10 mins):Health News:Hong Kong Government Invites Expressions of Interest in Development of Private Hospitals 2Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 2Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 3Health News:Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations 2Health News:Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 2Health News:Serious Gaps Revealed in U.S. Response to Health Emergencies 3[0] Hong Kong Government Invites Expressions of Interest in Development of Private Hospitals[0] ATR: Baucus Earns Place on 2009 "Naughty" List[0] Parent Company of Two New Jersey Hospitals to Pay U.S. $7.95 Million to Settle False Claims Act Allegations[0] Wider Adult Screening May Mean Fewer Children With Cystic Fibrosis [0] Serious Gaps Revealed in U.S. Response to Health Emergencies
AchilesOrthosisTurnbuckleFootdropStirrupSoleTriLensEpikeratomeSESAestheticTrexAU400AU640Intracanalicular
Other Tagskind 2kind 3kind 4kind 5kind 6kind 7kind 8kind 9kind 10salmon 2spatial 2spatial 3spatial 4die 2die 3die 4die 5die 6die 7die 8die 9die 10fast 2fast 3fast 4fast 5fast 6fast 7fast 8recognition 2recognition 3recognition 4recognition 5recognition 6| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |